The Beauty Tech Group (TBTG) H1 2026 TU earnings summary

Executive summary

• Upgraded full-year expectations following strong H1 FY26 performance, with revenue and adjusted EBITDA now anticipated to exceed previous guidance.

• Significant growth achieved across core business segments and all key markets and channels in the first half of FY26.

• Continued investment in research and clinical studies supports ongoing demand and brand awareness.

Financial highlights

• H1 FY26 revenue expected to be materially ahead of the prior year period.

• Full-year revenue now forecasted at no less than £170 million, up from previous market expectation of £161.7 million.

• Adjusted EBITDA for FY26 projected at no less than £45 million, compared to prior expectation of £41.5 million.

• Margin improvement driven by strong performance and a well-invested operating model.

Outlook and guidance

• Board anticipates revenue and adjusted EBITDA for FY26 will be ahead of current market expectations.

• Positive momentum expected to continue into H2 FY26, supported by upcoming product launches and market growth.

• Interim results for H1 FY26 to be published in September 2026.